Hydroxychloroquine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Condition:   Extra Pulmonary Sarcoidosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Hydroxychloroquine;   Drug: Lipiodol;   Drug: Placebo Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials